Faculty


INVITED FACULTY

Click on the thumbnail below to read more on our faculty members

    Professor Jeroen J. Bax (The Netherlands)
    Jeroen J. Bax is Professor of Cardiology and Director of non-invasive cardiac imaging, at the Department of Cardiology, Leiden University Medical Center.

    image
    Professor Jeroen J. Bax (The Netherlands)
    Jeroen J. Bax is Professor of Cardiology and Director of non-invasive cardiac imaging, at the Department of Cardiology, Leiden University Medical Center.

    He has been working intensively with the European Society of Cardiology (ESC), and is currently serving as President of the ESC.  He has been Associate Editor of the American College Cardiology, and is currently Associate Editor of the European Heart Journal.  He has co-authored numerous scientific articles, has guided many PhD fellows and his main interests of research include imaging in heart failure, stable coronary artery disease, valvular heart disease and atrial fibrillation.

    Close
    Professor Barbara Casadei
    Professor Barbara Casadei is a British Heart Foundation (BHF) Professor of Cardiovascular Medicine at the University of Oxford.

    image
    Professor Barbara Casadei
    Professor Barbara Casadei is a British Heart Foundation (BHF) Professor of Cardiovascular Medicine at the University of Oxford.

    She is the Lead of the Myocardial Theme of the Oxford BHF Centre of Excellence and of the Cardiovascular Theme of the National Institute for Health Research Biomedical Research Centre.

    Professor Casadei graduated in Medicine (cum Laude & Gold Medal) at the University of Pavia, Italy and moved to Oxford in 1989 to undertake her clinical and research training. She was awarded the Joan and Richard Doll Fellowship at Green College in 1991, a DPhil in Cardiovascular Medicine in 1995, and a BHF Senior Research Fellowship in 2001.  

    Professor Casadei is a Fellow of the UK Academy of Medical Sciences and the current President of the European Society of Cardiology (ESC).

    Professor Casadei provides a clinical service at the Oxford University Hospitals NHS Trust’s John Radcliffe Hospital and leads a bench-to-bedside translational research programme, which spans from clinical trials to bench-based investigation in human tissue and cells with a focus on atrial fibrillation.

    Close
    Dr Taweesak Chotivatanapong (Thailand)
    Dr Taweesak Chotivatanapong is now The Chairman of International Academic Institute Program and Senior Consultant at Central Chest Institute of Thailand.

    image
    Dr Taweesak Chotivatanapong (Thailand)
    Dr Taweesak Chotivatanapong is now The Chairman of International Academic Institute Program and Senior Consultant at Central Chest Institute of Thailand.

    Dr Taweesak Chotivatanapong is now The   Chairman of International Academic Institute Program and Senior Consultant at Central Chest Institute of Thailand.

    He is now also serving as a PCU Director of Cardiovascular Surgery of Bangkok Heart Hospital, BDMS Hospital Network, Bangkok, Thailand.  He is a councillor member of the ASCVTS, active member of AATS and International Fellow Member of STS and ANZSCTS.

    During the last several years, he set up the Heart Care Foundation that he serves as the President of the foundation. The main activities of this foundation are to provide operations for valvular heart patients in the long waiting list and training for young surgeons under "Train the Trainer" program throughout Thailand and the region. Several Centre of Excellence for valve repair is now successfully established under this program.

    He also serves as Chairman COE of National Cardiovascular and Thoracic Disease Ministry of Public Health. After received his training for CVT surgery in Thailand, he got his further training in Australia and the USA. He is the immediate Past President of Society of Thoracic Surgeons of Thailand.

    Most of his research focused on Mitral Valve Repair, Ross operation for infective AV and especially in Rheumatic Valve Repair.

    Close
    Dr Jean Fajadet (France)
    Dr Jean Fajadet graduated from the University Hospital of Toulouse in 1984 and has more than 30 years of experience in the field of Interventional Cardiology.

    image
    Dr Jean Fajadet (France)
    Dr Jean Fajadet graduated from the University Hospital of Toulouse in 1984 and has more than 30 years of experience in the field of Interventional Cardiology.

    He is currently Co-director of the Interventional Cardiovascular Group at Clinique Pasteur which is the leading center in France and has been involved as principal investigator or co-investigator in several major clinical trials involving new technologies and devices in the field of interventional cardiology. He has written and co-authored many articles published in peer-reviewed journals such as EuroIntervention, JACC, Circulation, and European Heart Journal. He is fully dedicated to Education which is a paramount axis of his carreer. This includes the fellowship programme at Clinique Pasteur and active participation in many worldwide educational meetings (Europe, US, Asia and South America) throughout the year. Dr Fajadet is one of the co-founder and course director of the EuroPCR congress. He is also course director of GulfPCR-GIM and AICT/AsiaPCR, advisor of PCR Tokyo Valves, and course chairman of PCR-CIT China Chengdu Valves. Additionally, he is Fellow of the European Society of Cardiology and was President of EAPCI (European Association of Percutaneous Cardiovascular Interventions, a registered branch of the ESC) from 2011 to 2014.
    Close
    Professor Nicholas Ossei-Gerning (UK)
    Professor Nicholas Ossei-Gerning did his basic medical training at University College Hospital, London and his cardiology training in the Yorkshire Heart Centre and Interventional training at University of Alberta, Canada.

    image
    Professor Nicholas Ossei-Gerning (UK)
    Professor Nicholas Ossei-Gerning did his basic medical training at University College Hospital, London and his cardiology training in the Yorkshire Heart Centre and Interventional training at University of Alberta, Canada.

    Professor Nicholas Ossei-Gerning did his basic medical training at University College Hospital, London and his cardiology training in the Yorkshire Heart Centre and Interventional training at University of Alberta, Canada. He was a British Heart Foundation Junior Fellow, completing his London MD thesis on “genetics and risk of coronary artery disease”. He was appointed Consultant Interventional Cardiologist at the University Hospital of Wales(UHW), Cardiff in April 2003, where he set up several of the programmes in complex coronary interventions. At UHW, he conducted regular lectures to students and junior medical and ancillary staff on most subjects in cardiovascular medicine and won the Excellence Award as Clinical Tutor of the Year in 2013. He has extensive research experience and a large number of publications covering a wide range of cardiovascular issues. He has supervised PhD and Master’s students. He has been the Lead Clinician for the Chest Pain Service, and a Consultant appraiser and set up the Resistant Hypertension Group, which involves the use of interventional techniques for treating resistant hypertension. In Complex Coronary Interventions, he led the Chronic Total Occlusion team, and also on the Trans Aortic Valve Implantation (TAVI) team. He has been the Network Advisor for the Royal College of Physicians and the British Cardiovascular Society for South East Wales and has served on the Executive Board of the Welsh Cardiovascular Society and a member of the Medical Advisory Committee at the Spire Cardiff Hospital for 10 years. As an Interventional Cardiologist, he has travelled extensively nationally and internationally to speak on the same. He is a regular faculty member of British and European Cardiac Interventional Societies and on faculty of Africa Percutaneous Revascularisation. He is a leading authority on Vasculogenic erectile dysfunction (ED) and a member of the British, European and International Societies for Sexual Medicine and was also elected to be a member of the International Consultation for Urological Diseases He is a leading expert on Pudendal stenting for erectile dysfunction and organised the first international congress on the subject in Cardiff. He has also set up the world’s first truly multi-disciplinary team with International status to manage patients with ED. He was appointed Silas Dodu Chair of Cardiology and Distinguished Visiting Professor of Cardiology and Pudendology at the University of Cape Coast School of Medical Sciences in April 2015. He was honoured with Professor of Practice at the University of Wales Trinity Saint David in July 2016, for his work in Cardiology and ED, and currently exploring the psychological effects of Heart disease and ED, with professors of Fine Art and Psychology. He is currently, the Medical Director for Euracare Advancved Diagnostic and Heart Center in Accra. The main aim is to help change the face of Cardiology in Sub-Saharan Africa.
    Close
    Professor A.H Gershlick
    Professor A.H Gershlick has been a Consultant Cardiologist since 1990 and appointed Chair as Professor of Interventional Cardiology at University of Leicester 2008.

    image
    Professor A.H Gershlick
    Professor A.H Gershlick has been a Consultant Cardiologist since 1990 and appointed Chair as Professor of Interventional Cardiology at University of Leicester 2008.

    Major interests over the years have been in acute coronary syndromes and intervention for coronary artery disease. Was the first in the UK to undertake clinical brachytherapy, the first to implant a drug eluting stent and the first to treat a patient in the UK with stem cells from the leg muscle and the first to implant a Bio-absorbable stent (2010). Lead faculty for multiple major International meetings. Research interests over the years have covered the basic science/pre-clinical area as well as the application of proven basic concepts as applied to and assessed in the clinical arena. As long ago as the early 1990s his lab investigated ways of delivering drugs loaded onto the stents themselves in order to reduce the unwanted tissue response. In 1996 they published a benchmark pre-clinical study in Circulation that demonstrated the efficacy of drugs delivered locally in this way. Pre-clinical projects include assessing whether loading of stents with HIF- (a growth factor switch molecule) for treating difficult CTOs. He devised, ran and analysed the REACT trial and was co-PI of the NEJM published STREAM Trial on pharmaco-invasive strategy. Current UK ISS include CvLPRIT (JACC) on MVD intervention in STEMI and "REFLOW-AMI" on micro-vascular obstruction in STEMI. This helped change the US AHA/ACC and ESC Guidelines. he has held >£12 million in research grants and started a BHF funded trial (2018) on managing high risk N-STEMI patients as STEMI-like. Clinical research has also included being UK PI for a further 10 International trials. Major recent grants £1.8 million BHF RAPID-STEMI: 6.4 million euros EU EURO SHOCK Previously served on Department of Health Committee on primary angioplasty (NIAP) as well as on the same data-analysis Committee. he has represented to on NICE on 8 occasions, sat on the BHF Programme grants Committee and MRC DPFS translational research panel. he has sat as Senior Judge British Cardiac Society Young Investigators Award (2002), Chairman Awards Committee Junior Cardiologists Research Prize (2005), Scientific Information Officer British Cardiovascular Intervention Society, British Heart Foundation Projects Grants Committee (2002-210), Faculty member National and International Meetings, British Cardiac Society chairman sub-committee on the future of non-invasive imaging, Advisor to the European Guidelines Committee on percutaneous coronary angioplasty (2005), European representative to the American Heart Association Guidelines committee (2006), writing group European STEMI Guidelines. Programme committee British Cardiac Society 2006-2010 R7D Chair BCIS 2008-2012 MRC grants committee 2010 -2014 Awarded Inaugural British Cardiovascular Society Lifetime Achievement Award Jan 2017 Awarded University of Leicester Lifetime Achievement Award June 2017 he continues in full time cardiology practice including CCU, routine out-patients on-call and with a CHIP intervention practice
    Close
    Dr Grace Lin (USA)
    Dr. Grace Lin is a Consultant Cardiologist and Associate Professor of Medicine at the Mayo Clinic in Rochester, Minnesota. She completed her residency in Internal Medicine and Cardiology training at the Mayo Clinic and subsequently joined the faculty.

    image
    Dr Grace Lin (USA)
    Dr. Grace Lin is a Consultant Cardiologist and Associate Professor of Medicine at the Mayo Clinic in Rochester, Minnesota. She completed her residency in Internal Medicine and Cardiology training at the Mayo Clinic and subsequently joined the faculty.

    Dr Grace Lin is a Consultant Cardiologist and Associate Professor of Medicine at the Mayo Clinic in Rochester, Minnesota.  She completed her residency in Internal Medicine and Cardiology training at the Mayo Clinic and subsequently joined the faculty.  Dr Lin specializes in echocardiography and Advanced Heart Failure and is currently the Director of Heart Failure Services at Mayo Clinic and a member of the American College of Cardiology Heart failure and Transplant Council.  She is a member of the Mayo Echo Core Laboratory, which provides echocardiographic analysis for both national and international clinical trials.  Her research and clinical interests are in imaging for heart failure and arrhythmias, cardiac amyloidosis and cardio-oncology.  Dr Lin also directs the expansion of the Mayo Clinic Tutorials series, which creates enduring materials for both continuing medical education and fellows in training. 

    Close
    A/Professor Vuyisile Nkomo (USA)
    Dr Vuyisile Nkomo is an Associate Professor of Medicine and Consultant at the Department of Cardiovascular Diseases, Mayo Clinic and a Director of the Valvular Heart Disease Clinic.

    image
    A/Professor Vuyisile Nkomo (USA)
    Dr Vuyisile Nkomo is an Associate Professor of Medicine and Consultant at the Department of Cardiovascular Diseases, Mayo Clinic and a Director of the Valvular Heart Disease Clinic.

    Dr Vuyisile Nkomo is an Associate Professor of Medicine and Consultant at the Department of Cardiovascular Diseases, Mayo Clinic and a Director of the Valvular Heart Disease Clinic. His areas of interest include echocardiography and valvular heart disease epidemiology. 

    Dr. Nkomo received his Doctor of Medicine (MD) degree from Meharry Medical College, Nashville, Tennessee, and completed Internal Medicine and Cardiology Fellowship training at Mayo Clinic, Rochester, Minnesota.  He also received his Masters in Public Health (MPH) from the University of Minnesota, Twin Cities, Minnesota, as part of his Cardiology Fellowship. 

    He is a Fellow of the American College of Cardiology (FACC), a Fellow of the American Society of Echocardiography (FASE) and an American Heart Association (AHA) volunteer expert.

    Close
    Professor Andrew Powell (USA)
    Dr Andrew Powell is a Senior Associate in Cardiology at Boston Children’s Hospital, and Professor of Pediatrics at Harvard Medical School.

    image
    Professor Andrew Powell (USA)
    Dr Andrew Powell is a Senior Associate in Cardiology at Boston Children’s Hospital, and Professor of Pediatrics at Harvard Medical School.

    Dr Andrew Powell is a Senior Associate in Cardiology at Boston Children’s Hospital, and Professor of Pediatrics at Harvard Medical School.

    He graduated from Harvard Medical School in 1992 followed by a residency in pediatrics and fellowship in pediatric cardiology, both at Boston Children’s Hospital. Afterward, he joined the staff there in the Department of Cardiology, where he is currently the Chief of the Cardiac Imaging Division. He is also the current President of the Society for Cardiovascular Magnetic Resonance (SCMR). Dr. Powell specializes in cardiac magnetic resonance imaging and echocardiography.

    His research has focused on the development of quantitative MRI methods to guide therapy and predict outcomes of congenital and pediatric heart disease. He has published over 150 research papers, chapters, and review articles.

    Close
    Professor Simon Redwood (UK)
    Simon Redwood is Professor of Interventional Cardiology and an Honorary Consultant Cardiologist at St Thomas Hospital, London.

    image
    Professor Simon Redwood (UK)
    Simon Redwood is Professor of Interventional Cardiology and an Honorary Consultant Cardiologist at St Thomas Hospital, London.

    Professor Redwood qualified from St. George’s Hospital Medical School, London in 1987. He trained in Cardiology at The Royal London Hospital, The Royal Free Hospital and St. George’s Hospital, London. Interventional training was obtained at The Washington Cardiology Center, Washington, DC and Guy’s and St. Thomas’ Hospitals. Professor Redwood is Professor of Interventional Cardiology/ Honorary Consultant Cardiologist and Director of the Cardiac Catheter labs at St. Thomas’. He was President of the British Cardiovascular Intervention Society from 2012-1016. He has been performing Percutaneous Coronary Intervention for over 20 years and is trained in all aspects of adult interventional cardiology including IVUS, pressure wire, stent implantation, rotational atherectomy, laser angioplasty, and trans-catheter aortic valve implantation and percutaneous mitral valve interventions as well as interventions for heart failure including the Parachute device. His has particular interest in interventional cardiology based research including risk analysis and prediction of events post percutaneous coronary intervention, evaluation of coronary stents, coronary artery and myocardial physiology during ischaemia and the Interventional management of out-of hospital cardiac arrest. He runs an active research team, has over 200 publications, is lead editor of a major Interventional Cardiology textbook (Oxford Textbook of Interventional Cardiology, now in its second edition), has raised over £10m in grant funding and has supervised >18 MD/PhD theses.
    Close
    Professor Véronique L. Roger USA)
    Véronique L. Roger, MD, MPH graduated from France Medical School and the Minnesota School of Public Health. She is a member of the Association of American Physicians and Professor of Internal Medicine, and Professor of Epidemiology at the Mayo Clinic College of Medicine.

    image
    Professor Véronique L. Roger USA)
    Véronique L. Roger, MD, MPH graduated from France Medical School and the Minnesota School of Public Health. She is a member of the Association of American Physicians and Professor of Internal Medicine, and Professor of Epidemiology at the Mayo Clinic College of Medicine.

    Véronique L. Roger, MD, MPH graduated from France Medical School and the Minnesota School of Public Health. She is a member of the Association of American Physicians and Professor of Internal Medicine, and Professor of Epidemiology at the Mayo Clinic College of Medicine. She is a cardiologist, epidemiologist, and outcomes researcher. With an interest in the occurrence and outcomes of cardiovascular diseases.

    Dr Roger has served on the Mayo Clinic’s Board of Governors and Board of Trustees and was the founding Director of the Robert D. and Patricia E. Kern Center for the Science in Health Care Delivery, which focuses on the science of best practice. She is actively involved in initiatives relevant to the research use of clinical data.

    Dr Roger has also served within. the American Heart Association as well as the National Heart, Lung and Blood (NHLBI) of the National Institutes of Health.  

    Close
    Professor Enriquez Sarano (USA)
    Dr Sarano is a Professor of Medicine at the Mayo Clinic College of Medicine with a long-standing interest in valvular heart diseases, outcomes and imaging.

    image
    Professor Enriquez Sarano (USA)
    Dr Sarano is a Professor of Medicine at the Mayo Clinic College of Medicine with a long-standing interest in valvular heart diseases, outcomes and imaging.

    Dr Sarano is a Professor of Medicine at the Mayo Clinic College of Medicine with a long-standing interest in valvular heart diseases, outcomes and imaging.  He was Director of the Mayo Heart Valve Clinic for over ten years.  Dr Sarano’s research has focused on all types of valve diseases from the macroscopic mechanistic point of view to quantitative imaging to outcomes and criteria for intervention with a specific focus on studying the physiology and mechanisms of mitral regurgitation.  Over the years, Dr Sarano’s work has provided him with extensive experience in cardiac imaging; leading to the publication of more than 300 peer-reviewed manuscripts related to human cardiac valve disease.

    Close
    Professor Oliver Stumper (UK)
    Study of Medicine at University of Bonn, Germany, after having worked as a nurse for 2 years. House officer jobs in Cardiology, Cardiac Surgery and Anaesthetics. MD thesis on late results after VSD closure in 1988.

    image
    Professor Oliver Stumper (UK)
    Study of Medicine at University of Bonn, Germany, after having worked as a nurse for 2 years. House officer jobs in Cardiology, Cardiac Surgery and Anaesthetics. MD thesis on late results after VSD closure in 1988.

    Studied Medicine at University of Bonn, Germany, after having worked as a nurse for 2 years. House officer jobs in Cardiology, Cardiac Surgery and Anaesthetics.

    MD thesis on late results after VSD closure in 1988. Initial training in paediatric cardiology in Bonn before research fellowship in cardiac ultrasound at Erasmus University, Rotterdam, NL in 1989. Development of intraoperative epicardial ultrasound and paediatric trans­oesopha­geal echocardiography which led to PhD thesis in 1991.

    Training in neonatology and paediatric cardiology in Edinburgh and Birmingham, UK. Senior clinical research fellowship in interventional cardiology at Hospital Necker, Paris, France in 1996. Appointment as Consultant Paediatric Cardiologist at Birmingham Children’s Hospital in 1996 (ongoing).

    The focus of work shifted more towards interventional catheter across the whole range of congenital heart disease. Development of departmental database system from 1998. Design and build of state-of-the-art biplane catheter theatre and single plane hybrid theatre at BCH in 2010.

    Lead in Interventional cardiac catheterisation and hybrid therapies at BCH since 2011. Development and refinement of numerous interventional techniques in the management of the univentricular heart circulation and initial palliation of complex cyanotic congenital heart disease. Senior cardiologist for the complex cardiac surgical program (Norwood/Fontan, AV discordance and PAVSD with MAPCAs).

    Ongoing dedicated support to develop congenital heart disease programs in emerging countries.

    Close
    Dr Murali Vettath (India)
    Dr Murali Vettath is a new generation coronary surgeon – one of the handful of surgeons in the world, performing 100% of his coronary surgeries on beating heart (without the use of Heart Lung Machine) over the last 12 years, without conversion.

    image
    Dr Murali Vettath (India)
    Dr Murali Vettath is a new generation coronary surgeon – one of the handful of surgeons in the world, performing 100% of his coronary surgeries on beating heart (without the use of Heart Lung Machine) over the last 12 years, without conversion.

    He has been a pioneer and protagonist of this "cutting edge technology" and has trained numerous surgeons and anaesthesiologists in this field of cardiac surgery around the world.

    Dr Murali has 28 years-experience in Cardiothoracic and Vascular Surgery, including 19 years as Chief Cardiothoracic Surgeon. He has performed over 7500 open-heart surgeries with more than 4500 of them on beating heart for coronary artery bypass surgery with a mortality of less than 0.5%. He has only one conversion to the pump in the last 4000 odd OPCAB (Off-Pump Coronary Artery Bypass) surgeries.

    Dr Murali has been one of the few surgeons in the world, performing 100 percent of his OPCAB surgeries over the last 10 years without any conversion to the Heart Lung Machine and has performed three Heart transplantations in 2015 of which one of them has survived nearly 3 years - a first of its kind in north Kerala.

    Close